Russell Investments Group
KZR

Russell Investments Group’s Kezar Life Sciences KZR Stock Holding History

Russell Investments Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-643
Closed -$3.86K – 3746
2024
Q2 		$3.86K Buy
+643
New +$4.89K ﹤0.01% 3268
2023
Q4 		– Sell
-92
Closed -$1.09K – 3263
2023
Q3 		$1.09K Sell
92
-17,980
-99% -$319K ﹤0.01% 3336
2023
Q2 		$443K Sell
18,072
-11,452
-39% -$298K ﹤0.01% 2260
2023
Q1 		$924K Buy
29,524
+13,526
+85% +$783K ﹤0.01% 2011
2022
Q4 		$1.13M Buy
15,998
+744
+5% +$55.2K ﹤0.01% 1907
2022
Q3 		$1.31M Buy
15,254
+4,068
+36% +$395K ﹤0.01% 1804
2022
Q2 		$923K Buy
11,186
+200
+2% +$17.6K ﹤0.01% 1988
2022
Q1 		$1.82M Buy
10,986
+468
+4% +$67.2K ﹤0.01% 1676
2021
Q4 		$1.76M Buy
+10,518
New +$1.19M ﹤0.01% 1868
2020
Q4 		– Sell
-3,075
Closed -$148K – 3123
2020
Q3 		$148K Buy
3,075
+1,685
+121% +$80.6K ﹤0.01% 2891
2020
Q2 		$72K Buy
+1,390
New +$70.1K ﹤0.01% 2940
2019
Q3 		– Sell
-94
Closed -$7K – 3059
2019
Q2 		$7K Sell
94
-116
-55% -$18K ﹤0.01% 2829
2019
Q1 		$37K Buy
+210
New +$41.4K ﹤0.01% 2833

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Russell Investments Group's KZR Position: Q3 2024 in Review

Russell Investments Group sold out of Kezar Life Sciences (KZR) in Q3 2024, closing a stake of 643 shares — an estimated $3.86K sold.

Russell Investments Group first reported a position in KZR in Q1 2019 and held it in 13 quarters. The position peaked at $1.82M in Q1 2022. 59 funds tracked by Wall St. Rank hold KZR as of Q3 2024.

  • Russell Investments Group reported no remaining Kezar Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 643 Kezar Life Sciences shares in Q3 2024, an estimated $3.86K.
  • Russell Investments Group first reported a position in Kezar Life Sciences in Q1 2019 and held it in 13 quarters.
  • Russell Investments Group's Kezar Life Sciences position peaked at $1.82M in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.